EBioMedicine (Oct 2024)

Bifidobacterium longum and microbiome maturation modify a nutrient intervention for stunting in Zimbabwean infantsResearch in context

  • Ethan K. Gough,
  • Thaddeus J. Edens,
  • Lynnea Carr,
  • Ruairi C. Robertson,
  • Kuda Mutasa,
  • Robert Ntozini,
  • Bernard Chasekwa,
  • Hyun Min Geum,
  • Iman Baharmand,
  • Sandeep K. Gill,
  • Batsirai Mutasa,
  • Mduduzi N.N. Mbuya,
  • Florence D. Majo,
  • Naume Tavengwa,
  • Freddy Francis,
  • Joice Tome,
  • Ceri Evans,
  • Margaret Kosek,
  • Andrew J. Prendergast,
  • Amee R. Manges

Journal volume & issue
Vol. 108
p. 105362

Abstract

Read online

Summary: Background: Small-quantity lipid-based nutrient supplements (SQ-LNS), which has been widely tested to reduce child stunting, has largely modest effects to date, but the mechanisms underlying these modest effects are unclear. Child stunting is a longstanding indicator of chronic undernutrition and it remains a prevalent public health problem. The infant gut microbiome may be a key contributor to stunting; and mother and infant fucosyltransferase (FUT) phenotypes are important determinants of infant microbiome composition. Methods: We investigated whether mother-infant FUT status (n = 792) and infant gut microbiome composition (n = 354 fecal specimens from 172 infants) modified the impact of an infant and young child feeding (IYCF) intervention, that included SQ-LNS, on stunting at age 18 months in secondary analysis of a randomized trial in rural Zimbabwe. Findings: We found that the impact of the IYCF intervention on stunting was modified by: (i) mother-infant FUT2+/FUT3− phenotype (difference-in-differences −32.6% [95% CI: −55.3%, −9.9%]); (ii) changes in species composition that reflected microbiome maturation (difference-in-differences −68.1% [95% CI: −99.0%, −28.5%); and (iii) greater relative abundance of B. longum (differences-in-differences 49.1% [95% CI: 26.6%, 73.6%]). The dominant strains of B. longum when the intervention started were most similar to the proficient milk oligosaccharide utilizer subspecies infantis, which decreased with infant age and differed by mother-infant FUT2+/FUT3− phenotypes. Interpretation: These findings indicate that a persistently “younger” microbiome at initiation of the intervention reduced its benefits on stunting in areas with a high prevalence of growth restriction. Funding: Bill and Melinda Gates Foundation, UK DFID/Aid, Wellcome Trust, Swiss Agency for Development and Cooperation, US National Institutes of Health, UNICEF, and Nutricia Research Foundation.

Keywords